Funding the Future: unlocking capital to power the growth we need
12:00 am - 1:00 pmCompany overview
BGF invested in Intrapharm in August 2014 and supported the company's acquisition of three specialist pharma companies: Peckforton Pharmaceuticals, Alvedon, Aquamax.
Following a period of sustained growth, with revenues increasing from £4m to £12m during BGF’s investment, the business was acquired by German pharmaceutical company RIEMSER Pharma GmbH in November 2015 with all shareholders realising a strong return.
Company information
Head office
- Maidenhead
CEO
- Kevin James
COO
- Shafiq Choudhary
BGF office
BGF team
Investment date
- Aug 2014 - Nov 2015
Total BGF investment
- £2 million